Lv1
30 积分 2026-02-20 加入
Selective Prophylactic Embolisation to Prevent Type II Endoleak after Endovascular Aneurysm Repair: A Meta-analysis of Randomised Controlled Trials
9小时前
求助中
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
27天前
已完结
Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy
27天前
已完结
Concern Over Bearing Definition and Nomenclature in Rotary Blood Pumps
1个月前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2个月前
已完结
A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator
2个月前
已完结
Prasinezumab: what have we learned from PASADENA and PADOVA?
2个月前
已完结
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
2个月前
已完结
New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment
3个月前
已关闭
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis
3个月前
已完结
皖公网安备34019202002308
